ANDA 91295, held by Pharm Assoc. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 91295 (Cyproheptadine Hydrochloride), held by Pharm Assoc, was first approved by FDA on Mar 28, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 28, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride2MG/5ML ยท syrup;oral | Cyproheptadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters